Equity Profile

FMS

Fresenius Medical Care AG

Health CareHealth Care Services$12.6B

May5Tue

Pre-Earnings Brief

UpcomingQ1-2026After Close9:00 AM EDT

Company Snapshot

Fresenius Medical Care AG is a leading provider of products and services for individuals with chronic kidney failure. Operating in the health care sector, the company plays a crucial role in delivering dialysis services and related health care solutions, which are essential as the global population ages and the prevalence of kidney disease increases.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health, which investors closely monitor.

0.50

Revenue

Total revenue reflects the company's ability to generate sales and is critical for assessing growth potential.

4.6B

Wall Street expectations, options signals, track record, and call prep available with Pro.

FMS Q1-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-6.74%

Avg Stock Reaction

-1.23%

Last Quarter Recap

In Q1 2023, Fresenius Medical Care reported an EPS of $0.17, slightly below the expected $0.18, indicating challenges in meeting market expectations. The stock reacted with a minor decline of 0.09% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Fresenius Medical Care to report earnings of $0.50 per share on revenues of $4.6 billion for Q1 2026. The market is cautiously optimistic but remains wary due to the company's recent earnings history.

Bull Case

If Fresenius can exceed EPS expectations and show strong revenue growth, it may signal a turnaround in performance, boosting investor confidence.

Bear Case

Conversely, if the company misses earnings and revenue targets again, it could raise concerns about its operational efficiency and long-term growth prospects.

Key Metrics to Watch

EPS

0.50

Earnings per share is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue

4.6B

Total revenue reflects the company's ability to generate sales and is critical for assessing growth potential.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Fresenius Medical Care achieve an EPS of $0.50 or higher?

Exceeding this benchmark would demonstrate improved profitability and could positively influence investor sentiment.

What are the revenue figures compared to the expected $4.6 billion?

Revenue performance is crucial for assessing the company's growth trajectory and operational effectiveness.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for a recovery in Fresenius's operational efficiency, as recent investments in technology and service improvements could yield better-than-expected results.

Supporting Evidence

The options market is pricing in a 4.4% move, indicating expectations of volatility that may not align with the company's recovery efforts.

Fresenius has a history of surprising the market, and recent strategic initiatives may not be fully reflected in current estimates.

Key Risk

If the company can demonstrate a significant improvement in revenue generation, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it follows a trend of missed expectations, and the market is keenly watching for signs of recovery.

Bull Confirmed If

An EPS of $0.53 or higher would confirm strong operational recovery and growth potential.

Bear Confirmed If

An EPS below $0.47 would indicate ongoing challenges and could lead to further declines in stock price.

Pre-Earnings Positioning

Options Market

Implied Move

±4.4%

Historical Avg

±2.7%

Pricing rich

The options market is pricing in a significant move around the earnings report, suggesting that investors are anticipating volatility.

Options are pricing ±4.4% while FMS has averaged ±2.7% over the last 8 prints — setup is pricing rich.

Detail

30d HV

22.1%

Calls (300)P/C Ratio: 1.00Puts (0)

Edge

Institutional Ownership

Smart-money positioning from the most recent 13F filings.

Top holders trimming

Institutional

8.64%

of float

Insider

0.00%

of float

Holders

255

institutions

Top Holders· as of Dec 2025

Pzena Investment Management LLC
14,752,836 sh · $335.9M
2.64%
-0.4%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Fresenius beats expectations, history suggests the stock could rise, confirming a positive turnaround narrative.

In-Line / Cautious

An inline result may lead to a muted response, with management commentary likely driving the stock's movement.

Miss

If the company misses, history suggests a potential decline of around 1.23%, reflecting ongoing concerns about its performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on profitability.
2Insights into patient growth and demand for dialysis services.
3Comments on competitive pressures and market share trends.
4Updates on new product launches or service enhancements.
5Management's outlook on future earnings and revenue growth.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health, which investors closely monitor.

0.50

Revenue

Total revenue reflects the company's ability to generate sales and is critical for assessing growth potential.

4.6B

Wall Street expectations, options signals, track record, and call prep available with Pro.

FMS Q1-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-6.74%

Avg Stock Reaction

-1.23%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Fresenius can exceed EPS expectations and show strong revenue growth, it may signal a turnaround in performance, boosting investor confidence.

Bear Case

Conversely, if the company misses earnings and revenue targets again, it could raise concerns about its operational efficiency and long-term growth prospects.

Key Metrics to Watch

EPS

0.50

Earnings per share is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue

4.6B

Total revenue reflects the company's ability to generate sales and is critical for assessing growth potential.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Fresenius Medical Care achieve an EPS of $0.50 or higher?

Exceeding this benchmark would demonstrate improved profitability and could positively influence investor sentiment.

What are the revenue figures compared to the expected $4.6 billion?

Revenue performance is crucial for assessing the company's growth trajectory and operational effectiveness.

Edge

What the Street Is Missing

Why consensus could be wrong

Supporting Evidence

The options market is pricing in a 4.4% move, indicating expectations of volatility that may not align with the company's recovery efforts.

Fresenius has a history of surprising the market, and recent strategic initiatives may not be fully reflected in current estimates.

Key Risk

If the company can demonstrate a significant improvement in revenue generation, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it follows a trend of missed expectations, and the market is keenly watching for signs of recovery.

Bull Confirmed If

An EPS of $0.53 or higher would confirm strong operational recovery and growth potential.

Bear Confirmed If

An EPS below $0.47 would indicate ongoing challenges and could lead to further declines in stock price.

Pre-Earnings Positioning

Options Market

Implied Move

±4.4%

Historical Avg

±2.7%

Pricing rich

The options market is pricing in a significant move around the earnings report, suggesting that investors are anticipating volatility.

Options are pricing ±4.4% while FMS has averaged ±2.7% over the last 8 prints — setup is pricing rich.

Detail

30d HV

22.1%

Calls (300)P/C Ratio: 1.00Puts (0)

Edge

Institutional Ownership

Smart-money positioning from the most recent 13F filings.

Top holders trimming

Institutional

8.64%

of float

Insider

0.00%

of float

Holders

255

institutions

Top Holders· as of Dec 2025

Pzena Investment Management LLC
14,752,836 sh · $335.9M
2.64%
-0.4%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Fresenius beats expectations, history suggests the stock could rise, confirming a positive turnaround narrative.

In-Line / Cautious

An inline result may lead to a muted response, with management commentary likely driving the stock's movement.

Miss

If the company misses, history suggests a potential decline of around 1.23%, reflecting ongoing concerns about its performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on profitability.
2Insights into patient growth and demand for dialysis services.
3Comments on competitive pressures and market share trends.
4Updates on new product launches or service enhancements.
5Management's outlook on future earnings and revenue growth.